North Shore Equity Rotation ETF (KOOL)

Cesca Therapeutics Inc. (KOOL) is a California-based medical technology company that focuses on developing and commercializing innovative cell-based therapeutics. The company is engaged in the research, development, and marketing of medical devices and therapies that enable the collection, separation, storage, and delivery of cell-based therapies. Cesca has a portfolio of proprietary products and technologies that are designed to address the needs of the regenerative medicine and cell therapy markets.

Cesca's proprietary technologies include its AXP AutoXpress Platform, which is a fully automated, closed system for the rapid, efficient, and reliable processing of cell-based therapies. The AXP system is used for the collection, separation, and preservation of stem cells and other cells that are used in various cell-based therapies. The company's other proprietary technologies include the MarrowXpress (MXP) platform, which is used to concentrate stem cells from bone marrow, and the PXP system, which is used for the isolation and purification of platelets.

Cesca's products and technologies are used in various therapeutic areas, including orthopedics, vascular medicine, neurology, and oncology. The company's products and technologies are used by hospitals, clinics, and research institutions worldwide.

In addition to its product portfolio, Cesca has a strong intellectual property portfolio, with over 100 issued and pending patents. The company's patents cover various aspects of its technologies, including the AXP system, the MXP system, and the PXP system.

Cesca was founded in 1986 and went public in 2004.